Evidence map›Paper›PMID 27123847›Full record

ArticlePloS one2016

Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson's Disease.

M Murtaza, J Shan, N Matigian, M Todorovic, A L Cook, S Ravishankar, L F Dong, J Neuzil, P Silburn, A Mackay-Sim and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Unraveling the Link between Olfactory Deficits and Neuropsychiatric Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

M MurtazaEskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
J ShanEskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
N MatigianEskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
M TodorovicEskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
A L CookEskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
S RavishankarEskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
L F DongApoptosis Research Group, School of Medical Science, Griffith University, Southport, Queensland, Australia.
J NeuzilApoptosis Research Group, School of Medical Science, Griffith University, Southport, Queensland, Australia.
P SilburnEskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
A Mackay-SimEskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
G D MellickEskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
S A WoodEskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
Griffith University · AUUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease is a complex age-related neurodegenerative disorder. Approximately 90% of Parkinson's disease cases are idiopathic, of unknown origin. The aetiology of Parkinson's disease is not fully understood but increasing evidence implies a failure in fundamental cellular processes including mitochondrial dysfunction and increased oxidative stress. To dissect the cellular events underlying idiopathic Parkinson's disease, we use primary cell lines established from the olfactory mucosa of Parkinson's disease patients. Previous metabolic and transcriptomic analyses identified deficiencies in stress response pathways in patient-derived cell lines. The aim of this study was to investigate whether these deficiencies manifested as increased susceptibility, as measured by cell viability, to a range of extrinsic stressors. We identified that patient-derived cells are more sensitive to mitochondrial complex I inhibition and hydrogen peroxide induced oxidative stress, than controls. Exposure to low levels (50 nM) of rotenone led to increased apoptosis in patient-derived cells. We identified an endogenous deficit in mitochondrial complex I in patient-derived cells, but this did not directly correlate with rotenone-sensitivity. We further characterized the sensitivity to rotenone and identified that it was partly associated with heat shock protein 27 levels. Finally, transcriptomic analysis following rotenone exposure revealed that patient-derived cells express a diminished response to rotenone-induced stress compared with cells from healthy controls. Our cellular model of idiopathic Parkinson's disease displays a clear susceptibility phenotype to mitochondrial stress. The determination of molecular mechanisms underpinning this susceptibility may lead to the identification of biomarkers for either disease onset or progression.

Indexed as

ApoptosisCells, CulturedCell SurvivalElectron Transport Complex IHSP27 Heat-Shock ProteinsHumansHydrogen PeroxideMitochondriaOlfactory MucosaOxidative StressParkinson DiseaseRotenoneElectron Transport Complex IHSP27 Heat-Shock ProteinsHSPB2 protein, humanHydrogen PeroxideRotenone

Identifiers

PMID27123847
PMCPMC4849794
OpenAlexW2343145590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.